Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cancer Immunotherapy Market Grown from 2024 to 2025?

The size of the cancer immunotherapy market has shown swift expansion in recent times. Expected to escalate from $110.91 billion in 2024 to $125.68 billion in 2025 with a compound annual growth rate (CAGR) of 13.3%. The factors influencing this impressive growth during the historic period include an increased incidence of cancer, a marked preference for immunotherapy over traditional treatment methods, an upsurge in R&D activities for disease-specific treatments, heightened efficacy and precision of contemporary therapies, along with a burgeoning awareness of the shortcomings associated with conventional cancer treatments.

What Growth Rate Is Anticipated for the Cancer Immunotherapy Market in the Coming Years?

The market size of cancer immunotherapy is anticipated to witness swift expansion in the upcoming years. It is projected to reach $194.64 billion by 2029, with a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth during the forecast period include the escalating approval of innovative immunotherapies for treating cancer, increased demand for tailor-made medicine, a rise in the incidence of cancer diagnoses, substantial investment in clinical research to launch advanced treatments, and escalating awareness about cancer immunotherapy. The forecast period will also see significant trends such as the emergence of adoptive cell therapies like car-t cells, the usage of oncolytic viruses in cancer immunotherapy, the creation of individualized cancer vaccines, the application of artificial intelligence in immunotherapy research, and a heightened focus on real-world evidence and patient results in treatment decisions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp

Who Are the Leading Companies in the Cancer Immunotherapy Market?

Major companies operating in the cancer immunotherapy market include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, 3D Signatures Inc., Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, Kura Oncology Inc., MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Pulse Biosciences Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc.

What Are the Key Drivers of the Cancer Immunotherapy Market?

The surge in cancer diagnoses is projected to drive the growth of the cancer immunotherapy market. The rise in cancer rates worldwide can be attributed to factors such as tobacco use, alcohol consumption, obesity, physical inactivity, and environmental factors. This increase in cancer diagnoses is predicted to spur the demand for cancer immunotherapies, as more patients are willing to invest in medical treatments that offer better healing prospects and less pain. For instance, data from the European Union Science Hub, a branch of the Belgium-based European Commission’s Joint Research Centre, revealed that in October 2023, new cancer diagnoses grew by 2.3% over the prior two years, hitting 2.74 million in 2022. Correspondingly, deaths from cancer rose by 2.4% over the previous two years. Therefore, the growing incidence of cancer is expected to fuel the demand for cancer immunotherapy in the forecast period.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6768&type=smp

What Are the Key Market Segments in the Cancer Immunotherapy Industry?

The cancer immunotherapy market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

3) By End User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

4) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

What Are the Latest Trends in the Cancer Immunotherapy Market?

The increasing prominence of advanced technologies in cancer immunotherapy is a critical trend in the cancer immunotherapy market. The rise of treatments that leverage the immune system to recognize and target tumors through methods such as immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy represents a wave of new technologies. These methods hold great promise for transforming cancer treatment outcomes. For instance, AstraZeneca plc, a pharmaceutical and biotech firm based in the UK, secured approval for its Capivasertib, combined with Faslodex, in October 2022. This immunotherapeutic cancer drug is specifically designed for breast cancer treatment, proving effective post-recurrence or progression following endocrine therapy in locally advanced or metastatic breast cancer with low or non-existent human epidermal growth factor receptor 2 (HER2).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report

What Are the Key Regional Markets in the Cancer Immunotherapy Industry?

North America was the largest region in the cancer immunotherapy market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6768

This Report Delivers Insight On:

1. How big is the cancer immunotherapy market, and how is it changing globally?

2. Who are the major companies in the cancer immunotherapy market, and how are they performing?

3. What are the key opportunities and risks in the cancer immunotherapy market right now?

4. Which products or customer segments are growing the most in the cancer immunotherapy market?

5. What factors are helping or slowing down the growth of the cancer immunotherapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model